A controversial bill proposal to privatize Israel’s Public Broadcasting Corporation, KAN, will not advance, Knesset Economic Affairs Committee chairman MK David Bitan (Likud) announced at a ...
The study data serves as the first symptomatic clinical proof of concept for KAN-101 and its potential as a disease-modifying treatment for celiac disease. KAN-101 induces antigen-specific immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback